2065438+February 2002, the first staff meeting of Sinopharm Health Industry (Shanghai) Co., Ltd. was successfully held.
20 1 1 At the end of the year, Shanghai Peibaokang Enterprise Management Co., Ltd. was officially renamed as Sinopharm Health Industry (Shanghai) Co., Ltd., and became a platform enterprise of health nutrition and professional health services under China Pharmaceutical Group and Sinopharm Holdings Co., Ltd.
On August 20 10, Shanghai peibaokang industrial co., ltd and sinopharm holdings co., ltd finally reached a cooperation and established "Shanghai peibaokang enterprise management co., ltd" as the main operating enterprise after the cooperation between the two parties.
July 20 10, the original American imported product "Avidi" (vitamin D3 drops) went on the market. On February 4th, 65438, "Expert Exchange Meeting on Clinical Application of Vitamin D3 in Maternal and Infant Health" was successfully held in Shanghai Daketang Pu 'er Club.
In July, 2065438+00, a new "breast enhancement" for pregnant women was introduced.
On June 20 10, milk calcium +ALA gel candy developed for preschool children went on the market.
In 2009, the company owned the whole office building on the 4th floor of Ke Rong Building in Huangpu District, Shanghai, and officially moved in in June165438+1October.
On June 1 day, 2009, a strategic agreement was reached with Italian company GNOSIS to introduce "GK" formula into China.
In 2009, American imported products "DHA for Life of Lefuzhi" and "Changmin" probiotics went on the market.
In May 2008, Shanghai Peibaokang Biotechnology Co., Ltd. completed the shareholding system reform, and in the same month, "Ziliqi" shark liver oil was listed.
In September 2007, "Probiotics and Children's Intestinal Health Seminar and Ma Lun Mushroom China Listing Conference" was successfully held in the International Conference Hall of Shanghai Science Museum, and Ma Lun mushroom probiotics were listed.
In 2007, liquid milk calcium fortified by adult milk was introduced.
In February, 2007, we reached a cooperative development agreement with American Life Constant Company, and devoted ourselves to the development and industrialization of functional health products.
In July 2006, it reached a cooperation and development agreement with the School of Pharmacy of Fudan University. In the same year, "Avril" was listed as the first product jointly developed by both parties.
On June 5438+ 10, 2006, we established a long-term strategic cooperative relationship with the Tang Center of the University of Chicago.
In 2005, the baby calcium supplement product "Rujiali" was successfully listed.
In 2004, Shanghai Peibaokang Biotechnology Co., Ltd. was established, specializing in the research, development and operation of pregnant and baby products.